Neurofibromatosis type 1 (NF1) is a frequent hereditary disorder that involves tissues derived from the embryonic neural crest. Besides the functional gene on chromosome arm 17q, NF1-related sequences (pseudogenes) are present on a number of chromosomes including 2, 12, 14, 15, 18, 21, and 22. We elucidated the complete nucleotide sequence of the NF1 pseudogene on chromosome 22. Only the middle part of the functional gene but not exons 21-27a, encoding the functionally important GAP-related domain of the NF1 protein, is presented in this pseudogene. In addition to the two known NF1 pseudogenes on chromosome 14 we identified two novel variants. A phylogenetic tree was constructed, from which we concluded that the NF1 pseudogenes on chromosomes 2, 14, and 22 are closely related to each other. Clones containing one of these pseudogenes cross-hybridised with the other pseudogenes in this subset, but did not reveal any in situ hybridisation with the functional NF1 gene or with NF1 pseudogenes on other chromosomes. This suggests that their hybridisation specificity is mainly determined by homologous sequences flanking the pseudogenes. Strong support for this concept was obtained by sequence analysis of the flanking regions, which revealed more than 95% homology. We hypothesise that during evolution this subset of NF1 pseudogenes initially arose by duplication and transposition of the middle part of the functional NF1 gene to chromosome 2. Subsequently, a much larger fragment, including flanking sequences, was duplicated and gave rise to the current NF1 pseudogene copies on chromosomes 14 and 22.
Introduction
Neurofibromatosis type 1 (NF1) is a frequent autosomal disorder with an incidence of approximately 1 in 3000 births. The disease involves tissues derived from the embryonic neural crest and the most important clinical features of the disorder are multiple neurofibromas, café-au-lait spots and Lisch nodules of the iris. The NF1 gene, located on chromosome 17q11.2, consists of 59 exons distributed over 350 kb of genomic DNA and encodes a protein of 2818 amino acids, called neurofibromin. 1 Neurofibromin contains a central domain showing homology to the catalytic domain of mammalian GTPase-activating proteins (GAPs). 2 The GAPrelated domain (GRD), encoded by exons 21-27a, stimulates the intrinsic GTPase-activity of the proto-oncogene ras p21. By converting ras p21 from the GTP-to the GDP-bound form, the activity of ras p21 is down-regulated. In recent years, numerous NF1-related sequences (pseudogenes) have been identified on various chromosomes, including 2, 12, 14, 15, 18, 21, and 22. [3] [4] [5] [6] [7] [8] [9] [10] [11] Most of the NF1 pseudogenes have been mapped to pericentromeric regions.
The chromosome 2 NF1 pseudogene has been localised in region 2q21, which is known to contain the remnant of an ancestral centromere. 12 NF1-related sequences are classified as non-processed pseudogenes, as partial sequence analysis revealed a conserved exon-intron organisation. On chromosomes 14 and 15, respectively two and three different NF1 pseudogene copies have been found. [3] [4] [5] 7, 10, 11 In this study, we investigated the mechanism of spreading of NF1 pseudogenes, in particular those on chromosomes 2, 14, and 22. In a previous report, 9 we showed that cosmids containing the chromosome 22 NF1 pseudogene only crosshybridise with the NF1 pseudogene regions on chromosomes 2 and 14. No hybridisation was detected with NF1-related loci on other chromosomes or with the functional NF1 gene. To explain this apparent lack of crosshybridisation, we suggested that the NF1-related loci on chromosomes 2, 14, and 22 form a subset of NF1 pseudogenes that are highly related to each other. To demonstrate this, we determined exactly which exons are represented in the NF1 pseudogenes on chromosomes 2, 14, and 22 and we established their evolutionary relationship. In addition, we sequenced regions flanking the NF1 pseudogenes on these chromosomes and show that these are highly homologous to each other. 
Materials and methods

Southern blot analysis
PCR amplification and DNA sequencing
Primer sequences for amplification of region A (see Figure 1 ) were as follows: forward, 5'-CTGTTCTTCAGTTAGAGCTTAT-TACTC-3' and reverse, 5'-CTCACATACATTATCTCATTTCA-TACT-3'. Both this region and marker D22S111 were amplified using standard PCR conditions. Sequencing of cosmids 29A9, 29D1 and 127F6 9 was performed according to procedures described previously. 14 The derived sequences were compared to the sequence of the NF1 locus 15 and the cDNA sequence according to the NNFF International NF1 Genetics Analysis Consortium (http:/ /www.nf.org/nf1gene/nf1gene.cDNAtext.html). Selected regions in and flanking the NF1 pseudogenes on chromosomes 2 and 14 were sequenced on an Applied Biosystems Model 377 automated sequencer using the Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Perkin Elmer, Foster City, CA, USA).
Phylogenetic analysis
Phylogenetic analyses were performed on the exon-related sequences of the NF1 pseudogenes on chromosomes 2, 14 and 22 and the corresponding sequences of the functional NF1 gene using the PHYLIP package (http://evolution.genetics.washington.edu/phylip.html). The maximum parsimony tree was obtained by branch-and-bound algorithm and contiguous gaps were recoded as a single character prior to analysis. For the neighbour-joining method, the statistical support for each branch was determined in terms of branch length and bootstrap analysis, using 1000 iterations.
Results
In a previous study, we isolated cosmids that contain NF1-related sequences on chromosome 22. 9 FISH analysis with these cosmids using high stringency conditions not only showed a hybridisation signal in the pericentromeric region of chromosome arm 22q, but also in the pericentromeric region of chromosome arm 14q and in region 2q21, the latter known to contain the remnant of an ancestral centromere. As these cosmids did not hybridise to other NF1-related loci or to the functional gene on chromosome arm 17q, we suggested that the NF1-related loci on chromosomes 22, 14, and 2 are related to each other and form a subset of NF1 pseudogenes.
To determine which NF1-related exons are present in the pseudogene on chromosome 22, we hybridised PCR products of a large number of exons of the functional NF1 gene to Southern blots with digests of DNA extracted from a chromosome 22-only human ϫ mouse cell line. Humanspecific hybridising fragments were only detected for exons 10b, 12a-19a, and 27b (data not shown). The same results were obtained for cosmids 29A9, 29D1, and 127F6, suggesting that the entire chromosome 22 NF1 pseudogene is contained within these cosmids.
Next we determined the complete nucleotide sequence of these cosmids (GenBank Accession Nos AC002471, AC003064, AC005374). Only the middle part of the functional NF1 gene is represented in this pseudogene (Figure 1 For the NF1 pseudogenes on chromosomes 2 and 14, Southern blot analysis was performed using chromosome 2-only and chromosome 14-only cell lines. Like for chromosome 22, human-specific hybridising fragments were only detected for exons 10b, 12a-19a, and 27b (data not shown). Except for exons 16, 17 and 18, all hybridising HindIII fragments observed with chromosomes 2 and 14 were of the same length as those with chromosome 22. Exons 16, 17, and 18 hybridised on chromosome 22 with a fragment of 1.2 kb, on chromosome 2 with a fragment of 1.4 kb and on chromosome 14 with fragments of 1.2, 1.4, and 1.7 kb (Figure 2) . The three signals in the chromosome 14 lane were quantified. Assuming that the HindIII fragment of 1.7 kb represents one copy, we calculated that the fragments of 1.2 and 1.4 kb represent two and five copies, respectively. This suggests that eight copies of an NF1 pseudogene, which may differ from each other, are present on this chromosome 14.
To obtain clones with sequences from the NF1-related locus on chromosome 2, we screened a chromosome 2 cosmid library (LL02NC02) with PCR products of exon 15, 17, and 19a. Only one positive cosmid was found, clone 180H4. All exons represented in the NF1 pseudogene on chromosome 2 as well as the fusion of intron 19a to intron 27a were present in this cosmid and their sequences were determined (GenBank Accession Nos AF232292-AF232302).
Since a chromosome 14-specific library was not available, 15 clones containing NF1 homologous loci were obtained by screening a human female PAC library (RPCI6). Upon Southern blot analysis with exons 16, 17, and 18, seven of these clones showed HindIII fragments with a length of 1.2, 1.4, or 1.7 kb. FISH analysis revealed that these clones all hybridise to the pericentromeric regions of chromosome arms 22q and 14q and to 2q21. In addition, the transition of intron 19a to intron 27a could be PCR-amplified from these seven PACs. Sequence analysis showed that three clones were derived from chromosome 2. Two other clones carried sequences identical to those presented by Régnier et al 11 as
φNF1-14A (GenBank Accession Nos AF232248-AF232258) and φNF1-14B (GenBank Accession Nos AF232259-AF232269). A third clone, which we named φNF1-14C, showed a HindIII fragment for exons 16, 17, and 18 of the same length (1.4 kb) as the chromosome 2 NF1 pseudogene (Figure 2 ), but sequence analysis revealed that this clone originated from chromosome 14 rather than from chromosome 2 (GenBank Accession Nos AF232270-AF232280). The fourth clone, φNF1-14D (GenBank Accession Nos AF232281-AF232291), yielded the 1.7 kb HindIII fragment for exons 16, 17 and 18, which is present on chromosome 14, but absent on chromosomes 2 and 22 (Figure 2) . Compared with the exons in the functional NF1 gene, several base substitutions, insertions and deletions occur in the exons represented in the pseudogenes on chromosomes 2, 14, and 22. Nevertheless, they share a high degree of identity, as shown in Figure 3 . Phylogenetic analysis was performed by maximum parsimony using exonic sequences of the functional NF1 gene and the NF1 pseudogenes, with the functional gene as outgroup. Analysis by the neighbourjoining method resulted in the same evolutionary tree as was found by maximum parsimony and the nodes were supported under the bootstrap test. Although bootstrap analysis of the most parsimonious tree did not yield significant values, the overall results suggest that the NF1 pseudogenes can be divided into two groups; one that is formed by the pseudogene on chromosome 2 and another by the pseudogenes on chromosomes 14 and 22.
To investigate whether the homologies between the various NF1 pseudogene regions extend beyond the NF1 gene duplicated segments, we determined the nucleotide sequence of flanking regions. For this purpose, primer pairs were (Figure 1 ). The primers for D22S111 and those for region A, at about 1800 bp 3' of the last segment with homology to the functional NF1 gene (Figure 1 ), yielded PCR products in all clones. Each PCR product was sequenced and alignments of these sequences show at least 95% homology (Figure 4 ).
Figure 4
Alignments of sequences flanking the NF1 pseudogenes on chromosomes 2, 14, and 22. Primers for marker D22S111 and for region A in, respectively, the 5' and 3' flanking regions of the NF1 pseudogene on chromosome 22 (see Figure 1 ) were used to amplify by PCR the corresponding segments in the NF1 pseudogene regions on clones derived from chromosomes 2 and 14. The resulting sequences were compared to the sequence of marker D22S111 and of region A on chromosome 22.
Discussion
We have determined the complete sequence of the NF1 pseudogene on chromosome 22. As is shown in Figure 1 , only the middle part of the functional NF1 gene is represented and complex rearrangements accompanied its insertion. Exons 19b-27a were deleted, resulting in the fusion of intron 19a to intron 27a. This deletion includes exons 21-27a, which code for the functionally important GAP-related domain of the NF1 protein. Compared with the functional NF1 gene, the exon-intron structure of its representation in the chromosome 22 NF1 pseudogene is well conserved. The overall similarity between the sequenced regions of the functional gene and the pseudogene is 95%, with no difference in mutation rate between exons and introns.
We have identified two new NF1 pseudogenes on chromosome 14 (φNF1-14C and φNF1-14D) in addition to the two already known copies on that chromosome (φNF1-14A and φNF1-14B). 4, 7, 11 The phylogenetic tree in Figure 3 demonstrates that the new pseudogenes are highly related to the other pseudogenes on chromosomes 2, 14, and 22. Moreover, they all contain the same exons and the transition of intron 19a to intron 27a, the latter marking the deletion of the GAP-related domain encoding exons. As such, they differ from other NF1 pseudogenes, especially those on chromosome 15, in which representation of GAP-related domain encoding exons has been demonstrated. 3, 5, 10, 11 Based on their phylogenetic tree, Régnier et al 11 suggested a common ancestral sequence for the NF1 pseudogenes on chromosomes 2, 14, 15, and 22. Duplication and transposition of this ancestral sequence would have resulted in the NF1 pseudogenes that are now present on chromosomes 2 and 15. The results presented here indicate that this duplication process gave rise to NF1 pseudogene copies that differed already in the presence (chromosome 2) or absence (chromosome 15) of the deletion that includes the GAP-related domain encoding exons. Duplication and transposition of the NF1 pseudogene copy on chromosome 2 then may have resulted in the pseudogenes on chromosomes 14 and 22. Further duplication and transposition might then most likely have generated the multiple copies of NF1 pseudogenes currently present on chromosome 14. We demonstrated more than 95% sequence conservation in regions flanking the 5'-and 3'-ends of the NF1 pseudogenes on chromosomes 2, 14, and 22 (Figure 4 ). This high homology strongly suggests that during evolution of the ancestral NF1 pseudogene on chromosome 2, the sequences flanking this locus were also included in the subsequent duplication and transposition processes. The sequenced segments display no homology at all with the corresponding regions in the functional NF1 gene on chromosome 17. This absence of homology may explain why our clones, containing the NF1 pseudogenes on chromosomes 2, 14, and 22, did not reveal any in situ hybridisation with the functional NF1 gene on chromosome arm 17q, despite having 95% sequence homology in the represented part, or with other NF1-related loci. FISH experiments with neighbouring clones are in progress to determine whether or not these cross-hybridise with the NF1 pseudogenes on chromosomes 2 and 14. These studies will enable estimation of the length of the duplicated and transposed segment.
